A sensitive biosensor of endogenous Gα i activity enables the accurate characterization of endogenous GPCR agonist responses
Science Signaling · 2025
DOI: 10.1126/scisignal.adp6457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Alex Luebbers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA. Hauptthemen laut MEDLINE: Biosensing Techniques, GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The activation of heterotrimeric G proteins (Gαβγ) by G protein–coupled receptors (GPCRs) is a mechanism broadly used by eukaryotes to transduce signals across the plasma membrane and a target for many clinical drugs. Many optical biosensors commonly used for measuring GPCR-stimulated G protein activity rely on exogenously expressed GPCRs and/or G proteins, which compromise readout fidelity. Biosensors that measure endogenous signaling may interfere with the signaling process under investigation or have a limited dynamic range of detection, hindering applicability. Here, we developed an optical BRET-based biosensor, Gα i bONE-GO, that detects endogenous GTP-bound (active) Gα i upon stimulation of endogenous GPCRs more robustly than existing sensors of endogenous activity. Its design leverages the Gα i -binding protein GINIP as a high-affinity and specific detector of Gα i -GTP. We optimized this design to prevent interference with downstream G i -dependent signaling and to enable implementation in different experimental systems having endogenous GPCRs, including adenosine receptors in primary astroglial cells and opioid receptors in cell lines. In a neuronal cell line, Gα i bONE-GO revealed activation profiles indicating that several natural opioid neuropeptides acted as partial agonists, in contrast with their characterization as full agonists using biosensors that depend on exogenously expressed receptors and G proteins. The Gα i bONE-GO biosensor is a direct and sensitive detector of endogenous activation of Gα i proteins by GPCRs in different experimental settings but does not interfere with the subsequent propagation of signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
- Department of Biology, College of Arts & Sciences, Boston University, Boston, MA 02115, USA.
ORCID-Profile: Alex Luebbers, Remi Janicot, Jingyi Zhao, Clementine E Philibert, Mikel Garcia-Marcos
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Luebbers, A., Janicot, R., Zhao, J., Philibert, C. E., & Garcia-Marcos, M. (2025). A sensitive biosensor of endogenous Gα i activity enables the accurate characterization of endogenous GPCR agonist responses. Science Signaling. https://doi.org/10.1126/scisignal.adp6457
Vancouver
Luebbers A, Janicot R, Zhao J, Philibert CE, Garcia-Marcos M. A sensitive biosensor of endogenous Gα i activity enables the accurate characterization of endogenous GPCR agonist responses. Science Signaling. 2025. doi:10.1126/scisignal.adp6457
BibTeX
@article{Luebbers2025,
author = {Luebbers, Alex and Janicot, Remi and Zhao, Jingyi and Philibert, Clementine E and Garcia-Marcos, Mikel},
title = {A sensitive biosensor of endogenous Gα i activity enables the accurate characterization of endogenous GPCR agonist responses},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adp6457}
}
EUVIMED